seed
Stage
1
Investors
About
Cosomil develops a high-precision diagnostic technology based on single-molecule enzyme activity measurement in blood to support early disease diagnosis and pharmaceutical development, with a particular focus on early detection of pancreatic cancer.
Explore Cosomil, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.